These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26313861)

  • 21. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].
    Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z
    Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Spectrum of Cardiovascular Lesions Requiring Intervention in Adults After Kawasaki Disease.
    Gordon JB; Daniels LB; Kahn AM; Jimenez-Fernandez S; Vejar M; Numano F; Burns JC
    JACC Cardiovasc Interv; 2016 Apr; 9(7):687-96. PubMed ID: 27056307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease.
    Duan C; Du ZD; Wang Y; Jia LQ
    World J Pediatr; 2014 Aug; 10(3):232-7. PubMed ID: 25124974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and distribution of atrial natriuretic polypeptide in the ventricles of children with myocarditis and/or myocardial infarction secondary to Kawasaki disease: immunohistochemical study.
    Fujiwara T; Fujiwara H; Takemura G; Mukoyama M; Saito Y; Nakao K; Imura H; Nakano M; Baba K
    Am Heart J; 1990 Sep; 120(3):612-8. PubMed ID: 2143884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased serum Annexin A1 levels in Kawasaki disease with coronary artery aneurysm.
    Weng H; Peng Y; Pei Q; Jing F; Yang M; Yi Q
    Pediatr Res; 2021 Feb; 89(3):569-573. PubMed ID: 32316027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of monocyte chemotactic protein-1 in peripheral blood mononuclear cells of children with Kawasaki disease and its relation to coronary artery impairment].
    Zhang J; Gui YH; Yang Y
    Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):132-5. PubMed ID: 19099689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of TGF-β Signaling in Remodeling of Noncoronary Artery Aneurysms in Kawasaki Disease.
    Lee AM; Shimizu C; Oharaseki T; Takahashi K; Daniels LB; Kahn A; Adamson R; Dembitsky W; Gordon JB; Burns JC
    Pediatr Dev Pathol; 2015; 18(4):310-7. PubMed ID: 25856633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation.
    Martínez-Martínez E; Brugnolaro C; Ibarrola J; Ravassa S; Buonafine M; López B; Fernández-Celis A; Querejeta R; Santamaria E; Fernández-Irigoyen J; Rábago G; Moreno MU; Jaisser F; Díez J; González A; López-Andrés N
    Hypertension; 2019 Mar; 73(3):602-611. PubMed ID: 30612490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac biopsy of Kawasaki disease.
    Yutani C; Go S; Kamiya T; Hirose O; Misawa H; Maeda H; Kozuka T; Onishi S
    Arch Pathol Lab Med; 1981 Sep; 105(9):470-3. PubMed ID: 6895017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kawasaki disease and increased cardiovascular risk: Is there a link to circulating glycocalyx biomarkers?
    Jakob A; Bohlig S; König M; Nussbaum C; Dalla-Pozza R; Hermann M; Haas NA; Pastor-Villaescusa B
    Microvasc Res; 2022 Mar; 140():104269. PubMed ID: 34699846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Cardiac Galectin-3 Expression, Myocarditis, and Fibrosis in Chronic Chagas Disease Cardiomyopathy.
    Souza BSF; Silva DN; Carvalho RH; Sampaio GLA; Paredes BD; Aragão França L; Azevedo CM; Vasconcelos JF; Meira CS; Neto PC; Macambira SG; da Silva KN; Allahdadi KJ; Tavora F; de Souza Neto JD; Dos Santos RR; Soares MBP
    Am J Pathol; 2017 May; 187(5):1134-1146. PubMed ID: 28322201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kawasaki disease: late cardiovascular sequelae.
    Daniels LB; Gordon JB; Burns JC
    Curr Opin Cardiol; 2012 Nov; 27(6):572-7. PubMed ID: 23075819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiogenesis, tumor necrosis factor-alpha and procoagulant factors in coronary artery giant aneurysm of a fatal infantile Kawasaki disease.
    Pucci A; Martino S; Celeste A; Linari A; Tibaldi M; Camosso E; Muscio M; Barattia G; Riva C; Bartoloni G
    Cardiovasc Pathol; 2008; 17(3):186-9. PubMed ID: 18402791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual-source CT imaging of multiple giant coronary and axillary aneurysms in a child with Kawasaki disease.
    Jin B; Feng XY
    Eur Rev Med Pharmacol Sci; 2014; 18(14):1969-72. PubMed ID: 25027333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathological characteristics of myocarditis in acute-phase Kawasaki disease.
    Harada M; Yokouchi Y; Oharaseki T; Matsui K; Tobayama H; Tanaka N; Akimoto K; Takahashi K; Kishiro M; Shimizu T; Takahashi K
    Histopathology; 2012 Dec; 61(6):1156-67. PubMed ID: 23134515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary artery bypass grafting for Kawasaki disease.
    Guo HW; Chang Q; Xu JP; Song YH; Sun HS; Hu SS
    Chin Med J (Engl); 2010 Jun; 123(12):1533-6. PubMed ID: 20819507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support.
    Lok SI; Nous FM; van Kuik J; van der Weide P; Winkens B; Kemperman H; Huisman A; Lahpor JR; de Weger RA; de Jonge N
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):407-15. PubMed ID: 25609773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell adhesion molecule expression in coronary artery aneurysms in acute Kawasaki disease.
    Miura M; Garcia FL; Crawford SE; Rowley AH
    Pediatr Infect Dis J; 2004 Oct; 23(10):931-6. PubMed ID: 15602193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infliximab as a novel therapy for refractory Kawasaki disease.
    Weiss JE; Eberhard BA; Chowdhury D; Gottlieb BS
    J Rheumatol; 2004 Apr; 31(4):808-10. PubMed ID: 15088313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous γ-immunoglobulin therapy.
    Lin MT; Sun LC; Wu ET; Wang JK; Lue HC; Wu MH
    Arch Dis Child; 2015 Jun; 100(6):542-7. PubMed ID: 25564534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.